About this event

  • Date and time Mon 12 Jul 2021 from 4:30pm to 14 Jul 2021 at 6:05pm
  • Location Online
  • Organised by Endocrinology and Diabetes, Ophthalmology

Join top speakers in this unique three-day webinar series to explore how endocrine and diabetes disorders can affect the eye.

National experts in this field from both the endocrine and ophthalmology worlds will update registrars and consultants in both specialties about the latest developments in the diagnosis and management of eye disorders occurring in the context of endocrinopathies. This series will also incorporate the patient's perspective.

The first in a series of three webinars delivered by clinicians with demonstrated expertise in their field will focus on thyroid eye disease, neuro-ophthalmology, and genetics. In the second webinar, we will hear a patient will hear from a patient living with eye disorders and explore the latest developments in the diagnosis and management of thyroid eye disease. The third and final webinar will focus on the effect of endocrine drugs on the eye and the effect of eye treatments on endocrine axes 

Join in the conversation online
Follow us on Twitter: @RoySocMed

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

We would like to thank our sponsor Novo Nordisk for their support of these webinars. Please note that the sponsor has not had any influence or involvement over the agenda, content or organisation of these meetings. 

Key speakers

Professor Graham Leese

Consultant in Diabetes, Ninewells Hospital, Dundee

Speaker's biography

Professor Graham Leese is an NHS consultant at Ninewells Hospital Dundee and former lecturer at the University of Liverpool.  He has paralleled research interests and clinical developments especially in diabetic eye disease with screening, and diabetic foot disease with risk stratification.  He has interests in the epidemiology of these areas in addition to thyroid and parathyroid disease.  Professor Leese was involved in establishing retinal screening programmes in Scotland and the UK as a whole.  He has published over 250 papers in these areas.  Over the years he has been part of the Scottish Diabetes Group in a number or roles, including chairman of the Foot subgroup, Scottish Diabetes Research Network (as chairman), Clinical Team Leader and MCN chairman locally. He is NRS clinical lead for metabolic and endocrine research and is previous advisor to the CMO in general medicine and diabetes and endocrinology.  He has developed and established local clinical services in diabetes, endocrinology and osteoporosis.  He is also Associate Postgraduate Dean for Broad Based Training, and is past-chair of the SCE exam board, and current chair of the standard setting committee.

Dr Tom Eke

Consultant Ophthalmologist, Norfolk and Norwich University Hospitals

Speaker's biography

Mr Tom Eke has been a Consultant Ophthalmologist at Norfolk and Norwich University Hospitals for nearly 20 years.  His main interests are conditions affecting the optic nerves and visual fields (i.e. glaucoma, neuro-ophthalmology). He spends a lot of time looking at visual field plots that are done by optometrists (opticians) or in the hospital eye service, and a lot of time looking at the back of peoples’ eyes.  Most of the ‘non-diabetes endocrinology’ eye patients come through his clinic, so he has a lot of experience in assessing visual fields and fundi to find and monitor endocrinology patients.  He also sits on the DVLA’s national advisory panel (vision and driving). Mr Eke’s presentation should help you to understand visual field plots.  He will tell you how to get a good view of the optic discs with your ophthalmoscope, and how to understand what you are seeing.

Fabiana D'Esposito

Dr Fabiana D’Esposito

Consultant, Western Eye Hospital, Imperial College Ophthalmology Research Group Unit, Imperial NHS Trust
Speaker's biography

Dr Fabiana D’Esposito (MD, PhD) qualified summa cum laude as a medical doctor and then as an ophthalmologist at University of Naples “Federico II” (Italy). She completed her PhD in London at the Institute of Ophthalmology, Department of Molecular Genetics (UCL), under the supervision of Prof. Shomi Bhattacharya focusing on the molecular aspects of inherited eye diseases. In her working experience, she has been a post-doc research assistant at Imperial College in the Department of Molecular Genetics, School of Medicine and then coordinator of the Ophthalmic Genetics Section at CEINGE-Advanced Biotechnologies Institute, Naples, where she obtained the qualification as “Expert Researcher” by the Italian Ministry of Research and University. At present, she is an honorary senior lecturer in Ophthalmic Genetics at Imperial College and a consultant at the ICORG Unit, Western Eye Hospital, Imperial NHS Trust (London, UK). She is a visiting professor of Ophthalmic Genetics at University of Naples “Federico II”, and at University of Salerno (Italy). She is an advisor for the MAGI-Euregio laboratory of genetics (Bolzano, Italy) and for numerous ophthalmic clinics across Italy where she is counselling for patients affected by genetic eye conditions. Dr Fabiana D’Esposito is specialised in the study and in the management of inherited eye diseases (diagnosis, phenotype-genotype correlations and molecular characterization).

Mr Adi Latif

Accessibility Consultant, AbilityNet

Speaker's biography

Adi Latif is an accessibility consultant at AbilityNet. He empowers organisations on how to best design an inclusive product/ service which can be used by all, increasing market share and providing disabled people equal access. He believes that good design enables and empowers people and bad design disables. He’s experienced inaccessibility strategy, accessibility user testing and training.  He also has over 15 years of experience in using screen-reader technology for the blind.  Previous experience includes running two start-ups, the world’s first blind professional snowboarder and working for Accenture Global management consultancy. AbilityNet is a charity who works with large and small organisations from all sectors to improve the usability and accessibility of digital products and services.

Professor Colin Dayan

Professor Colin Dyan

Professor of Clinical Diabetes and Metabolism, Cardiff University

Speaker's biography

Colin Dayan trained in medicine at University College, Oxford, and Guy’s and Charing Cross Hospitals in London, before obtaining a PhD in the immunology of Graves’ Disease in Laboratory of Marc Feldmann. He spent a year as an endocrine fellow at the Massachussetts General Hospital in Boston, USA before completing his specialist training in diabetes and endocrinology, lecturing in Bristol. He became a consultant senior lecturer in medicine (diabetes/endocrinology) at the University of Bristol in 1995 and Head of Clinical Research at the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology in Bristol in 2002.

In 2010, he was appointed as Chair of Clinical Diabetes and Metabolism and Head of Section at Cardiff University. He served as Director of the Institute of Molecular and Experimental Medicine in 2011-2015. In 2020 he was appointed as Senior Clinical Researcher, Wellcome Centre for Human Genetics, University of Oxford as a joint post with Cardiff. He has a long-established interest in translational research in the immunopathology of type 1 diabetes (T1D), currently conducting early phase clinical trials in the development of antigen-specific immunotherapy as well as leading multicentre phase 2 studies. His clinical interests in diabetes include management of poor compliance in type 1 diabetes, public health measures in the prevention of type 2 diabetes and models of community care in diabetes.

He has been part of 2 major EU FP7 programme grants in T1D a member of the Juvenile Diabetes Research Foundation Medical and Scientific Committee and the Welsh Diabetes Research Unit. He currently leads the Clinical Engagement and Training Core of the Diabetes UK funded T1D UK immunotherapy Consortium which aims to coordinate and support combined efforts to bring immunotherapy for T1D into clinical practice. He also chairs the UK Clinical Studies Group for the prevention, targets and therapies in T1D.

Tas Braithwaite

Dr Tasanee Braithwaite

Consultant Ophthalmologist, The Medical Eye Unit, Guy’s and St Thomas’ NHS Foundation Trust and Honorary Senior Lecturer in Health Informatics and Ophthalmic Epidemiology, King’s College London

Speaker's biography

Tas Braithwaite is a Consultant Ophthalmologist specialising in inflammatory eye disease (uveitis and scleritis) and neuro-ophthalmology. She takes a particular interest in the holistic care of patients who have vision or eye problems resulting from systemic autoimmune, autoinflammatory and infectious diseases, and manages patients requiring systemic therapy including immunosuppression and biologic therapy.

She holds a dual appointment as Adjunct and Honorary Senior Lecturer in the School of Immunology and Microbial Sciences, and the School of Life Course Sciences, Kings College London. Her research programme aims to deliver predictive, preventive, personalised and participatory medicine to her patients, and to inform evidence-based practice internationally. Working with a network of global collaborators, she is developing tools to better quantify the impacts of eye disease on outcomes including quality of life, and advancing insights into the epidemiology of inflammatory eye diseases and associated risk factors. She serves as a Contact Editor for Cochrane Eyes and Vision and contributed a chapter on, ‘The Eye in General Medicine,’ to the Oxford Textbook of Medicine.

This presentation aims to provide a very brief overview of the many different ways in which drugs can affect the eyes and visual system.

Pearse Keane

Dr Pearse Keane

Consultant Ophthalmologist, Moorfields Eye Hospital Trust, Associate Professor, University College London, UK Research and Innovation Future Leaders Fellow

Speaker's biography

Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London, and an associate professor at UCL Institute of Ophthalmology. He is originally from Ireland and received his medical degree from University College Dublin (UCD), graduating in 2002.

In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In August 2018, the first results of this collaboration were published in the journal, Nature Medicine. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in many countries.

In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in June 2020, he was profiled in The Economist.

Professor Sobha Sivaprasad

Professor Sobha Sivaprasad

Professor and Consultant, Moorfields Eye Hospital and University College London

Speaker's biography

Professor Sivaprasad is a medical retina consultant and a clinical researcher in retinal vascular diseases and age-related macular degeneration. Her key research areas are retinal imaging markers, clinical trials, experimental medicine. She is the Editor in Chief of EYE and has over 300 peer-reviewed publications to her credit

Agenda

View the programme 12 July 2021

Welcome and introduction
Neuro-ophthalmology for endocrinologists

Mr Tom Eke, Consultant Ophthalmologist, Norfolk and Norwich University Hospitals

Rarer diseases, manifestations on the eye: Bardet-Biedl syndrome

Dr Fabiana D’Esposito, Consultant, Western Eye Hospital, Imperial College Ophthalmology Research Group Unit, Imperial NHS Trust

What's happening in diabetic eye disease?

Professor Graham Leese, Consultant in diabetes, Ninewells Hospital, Dundee

Panel discussion
Close of meeting
View the programme 13 July 2021

Welcome and introduction
A different point of view: From a blind patient’s perspective, what is out there that can help

Mr Adi Latif, Accessibility Consultant, AbilityNet

Thyroid eye disease and its medical management

Professor Colin Dayan, Professor of Clinical Diabetes and Metabolism, Cardiff University

Panel discussion
Close of meeting
View the programme 14 July 2021

Welcome and introduction
Drugs and the eye

Dr Tasanee Braithwaite, Consultant Ophthalmologist, The Medical Eye Unit, Guy’s and St Thomas’ NHS Foundation Trust and Hon Senior Lecturer in Health Informatics and Ophthalmic Epidemiology, King’s College London

Automated deep learning for diabetic eye disease: AI that can build AI

Dr Pearse Keane, Consultant Ophthalmologist, Moorfields Eye Hospital Trust, Associate Professor, University College London, UK Research and Innovation Future Leaders Fellow

The focus study? Changes in glycaemia and effects on diabetic retinopathy

Professor Sobha Sivaprasad, Professor and Consultant, Moorfields Eye Hospital and University College London

Panel discussion
Close of meeting

Sponsors

Location

Online

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Special rates for difficult times 
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic. 

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.